Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 159,588 275,693 319,053 656,089
Total Sell Value $13,270,852 $23,760,160 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 10 21 27 56
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 2582
  Page 7 of 104  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-03-10 4 OE $67.81 $1,017,150 D/D 15,000 502,856     -
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2023-02-28 4 A $0.00 $0 D/D 24,890 52,636     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-02-28 4 A $0.00 $0 D/D 167,532 487,856     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2023-02-28 4 A $0.00 $0 D/D 38,769 79,857     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2023-02-28 4 A $0.00 $0 D/D 68,052 212,146     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2023-02-28 4 A $0.00 $0 D/D 37,724 94,449     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2023-02-24 4 OE $67.81 $99,952 D/D 1,474 56,725     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-02-13 4 AS $109.15 $654,900 D/D (6,000) 320,324     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-02-13 4 OE $67.81 $406,860 D/D 6,000 326,324     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-02-10 4 AS $110.11 $1,651,650 D/D (15,000) 320,324     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-02-10 4 OE $67.81 $1,017,150 D/D 15,000 335,324     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-02-07 4 GA $0.00 $0 I/I 200 100     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-02-07 4 GD $0.00 $0 I/I 200 247,333     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2023-01-25 4 AS $115.65 $5,669,134 D/D (49,000) 41,088     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2023-01-25 4 OE $67.81 $3,322,690 D/D 49,000 90,088     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-01-17 4 AS $111.55 $1,115,500 D/D (10,000) 320,424     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-01-17 4 OE $67.81 $678,100 D/D 10,000 330,424     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-01-13 4 AS $112.25 $1,122,500 D/D (10,000) 320,424     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2023-01-13 4 OE $67.81 $678,100 D/D 10,000 330,424     -
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2023-01-13 4 AS $114.50 $286,250 D/D (2,500) 27,746     -
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2023-01-13 4 OE $63.10 $157,750 D/D 2,500 30,246     -
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2022-12-13 4 AS $107.50 $268,750 D/D (2,500) 27,746     -
   Mueller Brian EVP, Chief Financial Officer   •       –      –    2022-12-13 4 OE $63.10 $157,750 D/D 2,500 30,246     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-12-13 4 S $106.89 $106,890 D/D (1,000) 320,424     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-12-02 4 S $103.97 $155,967 D/D (1,500) 321,424     -
  2582 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 104
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us